Genmab A/S (GMAB)

Genmab Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	3,846	2,988	2,443	2,084	1,287	1,662
Revenue Growth (YoY)	29.57%	22.32%	17.23%	61.88%	-22.52%	106.20%
Cost of Revenue	216.74	136.74	33.52	-	-	-
Gross Profit	3,629	2,852	2,410	2,084	1,287	1,662
Selling, General & Admin	643.4	526.14	488.94	384.48	196.24	108.63
Research & Development	1,567	1,343	1,132	799.14	639.51	515.54
Operating Expenses	2,211	1,869	1,620	1,184	835.75	624.17
Operating Income	1,418	982.72	789.09	900.43	451.68	1,037
Interest Expense	-25.85	-16.66	-10.38	-5.6	-1.99	-1.64
Interest & Investment Income	134.31	138.13	145.63	46.55	30.13	30.24
Currency Exchange Gain (Loss)	185.35	185.88	-131.84	151.01	224.85	-239.28
EBT Excluding Unusual Items	1,712	1,290	792.5	1,092	704.67	826.8
Merger & Restructuring Charges	-8.13	-41.65	-	-	-	-
Gain (Loss) on Sale of Investments	87.8	34.29	43.45	-94.54	-105.39	143.47
Asset Writedown	-11.94	-10.55	-	-	-	-
Pretax Income	1,780	1,272	835.95	997.85	599.28	970.27
Income Tax Expense	196.37	183.25	190.56	214.51	146.99	188.34
Net Income	1,583	1,089	645.39	783.33	452.29	781.94
Net Income to Common	1,583	1,089	645.39	783.33	452.29	781.94
Net Income Growth	125.14%	68.72%	-17.61%	73.19%	-42.16%	140.38%
Shares Outstanding (Basic)	63	64	65	65	65	65
Shares Outstanding (Diluted)	63	65	66	66	66	66
Shares Change (YoY)	-3.12%	-1.94%	-0.14%	-0.06%	0.24%	3.53%
EPS (Basic)	25.24	16.96	9.88	11.98	6.92	12.00
EPS (Diluted)	25.10	16.85	9.79	11.87	6.85	11.87
EPS Growth	132.41%	72.08%	-17.49%	73.29%	-42.30%	132.20%
Free Cash Flow	1,328	1,053	1,040	516.52	302.24	1,007
Free Cash Flow Per Share	21.06	16.29	15.78	7.83	4.58	15.28
Gross Margin	94.36%	95.42%	98.63%	100.00%	100.00%	100.00%
Operating Margin	36.88%	32.89%	32.30%	43.21%	35.08%	62.44%
Profit Margin	41.17%	36.44%	26.42%	37.59%	35.13%	47.06%
Free Cash Flow Margin	34.54%	35.23%	42.58%	24.79%	23.48%	60.59%
EBITDA	1,473	1,026	819.93	941.81	481.35	1,075
EBITDA Margin	38.30%	34.33%	33.56%	45.19%	37.39%	64.71%
D&A For EBITDA	54.86	43.17	30.85	41.38	29.67	37.8
EBIT	1,418	982.72	789.09	900.43	451.68	1,037
EBIT Margin	36.88%	32.89%	32.30%	43.21%	35.08%	62.44%
Effective Tax Rate	11.03%	14.40%	22.80%	21.50%	24.53%	19.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q